PNZ5

CAS No. 1629277-36-6

PNZ5( —— )

Catalog No. M26388 CAS No. 1629277-36-6

PNZ5 is a potent and isoxazole-based pan-BET inhibitor, with high selectivity and potency similar to the well-established (+)-JQ1.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 253 In Stock
5MG 256 In Stock
10MG 375 In Stock
25MG 562 In Stock
50MG 775 In Stock
100MG 1042 In Stock
200MG 1414 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PNZ5
  • Note
    Research use only, not for human use.
  • Brief Description
    PNZ5 is a potent and isoxazole-based pan-BET inhibitor, with high selectivity and potency similar to the well-established (+)-JQ1.
  • Description
    PNZ5 is a potent and isoxazole-based pan-BET inhibitor, with high selectivity and potency similar to the well-established (+)-JQ1, with a KD of 5.43 nM for BRD4.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Epigenetic Reader Domain
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1629277-36-6
  • Formula Weight
    318.376
  • Molecular Formula
    C20H18N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [H][C@]1(N(C)C(=O)c2ccc(cc12)-c1c(C)noc1C)c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ye, C., Jin, M., Jin, C. et al. Inhibitory Effects of Chemical Constituents from Actinidia kolomikta on LPS-Induced Inflammatory Responses. Rev. Bras. Farmacogn. 30, 127–131 (2020).
molnova catalog
related products
  • ZL0580

    ZL0580 induces HIV suppression by inhibiting Tat transactivation and transcription elongation as well as by inducing repressive chromatin structure at the HIV promoter.

  • NEO2734

    NEO2734 is an orally active and selective inhibitor of p300/CBP and BET bromodomain(IC50 of <30 nM for both p300/CBP and BET bromodomains).

  • PBRM1-BD2-IN-8

    PBRM1-BD2-IN-8 (compound 34) is a potent PBRM1 Bromodomain inhibitor with PBRM1-BD2 Kd of 4.4 μM, PBRM1-BD2 IC50 of 0.16 μM, and PBRM1-BD5 Kd of 25 μM; PBRM1-BD2-IN-8 shows anti-cancer activity.